Vancouver, BC, December 12, 2016 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce it has entered into a consulting agreement with Cannera Consultants (“Cannera”) and has enlisted Phillip Hague to undertake the role of Chief Science Officer and Head of Horticulture.

Cannera, a division of the GreenTec Bio-Pharmaceuticals Group has entered into an agreement with Invictus MD to oversee all Canadian assets and acquisitions within the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), and provide assistance with certain U.S. acquisitions. Cannera, which was the intermediary party in bridging Invictus MD with AB Laboratories Inc, has played an integral role in negotiating and executing the Binding Letter of Intent for this Licensed Producer, signed by both parties on November 23rd, 2016. Cannera’s vast rolodex and expertise in the industry will play a pivotal role in Invictus MD’s aggressive North America wide conquest.

Cannera currently operates and manages all cultivation duties at an ACMPR Licensed Producer in British Columbia, which was one of the original 13 Licensed Producers. As of January 2nd, 2017, Cannera will assume the role of “Head of ACMPR Business Development” & “Head of ACMPR Operations” for Invictus MD. Cannera’s Senior Consultant sits on the advisory board of Doventi Capital Inc (a legal Cannabis Private Equity Fund), and is the Senior Operations Manager of GreenTec Nevada Holdings, which Invictus MD has secured an Option to purchase up to 60% of.

Phillip Hague will assume the role of Head of Horticulture for the United States. Mr. Hague is currently managing a State licensed cultivation facility in Chicago Illinois that is 120,000 square feet, and a New York state licensed facility that is 320,000 square feet. Mr. Hauge comes from a traditional large-scale commercial controlled agriculture environment, and brings a lifetime of passion and experience into the industry. He is recognized as one of the industry’s most sought after consultants. He has designed, built, staffed and maintained over 1,000,000 square foot of indoor cannabis cultivation and more than 20 acres of greenhouse facilities.

After transitioning from traditional horticulture into the cannabis space Phillip quickly built some of the most recognizable and successful brands in the cannabis industry, gaining the respect and interest of his peers and the media. Winner of multiple awards including several prestigious Cannabis Cups, Phillip has been featured in numerous articles and news programs on the cannabis industry including National Geographic’s “the science of weed”, 60 minutes “The Marijuana Effect”, Rolling Stone’s “too high to fail”, Chicago Sun Time’s “A New Crop”, as well as multiple industry publications and news magazines such as CNN, MSNBC, Wall Street Journal and many others.

 

Dan Kriznic, CEO commented “These are fundamental additions to Invictus MD’s management and growth team, both Phillip and Cannera are highly sought after consultants and bring a track record of proven results and success. With Canada’s task force developing the legal framework behind recreational legalization and the recent U.S. states that have voted in favour of legalizing cannabis for medical or recreational, we are pleased more than ever to aggressively focus on building a cultivation platform across North America, as well as Future Harvest’s brand recognition globally. 2017 will be a victorious year for Invictus MD and its shareholders as we navigate across the North American legal cannabis sector and its ancillary support verticals”

About Invictus MD Strategies Corp.

Invictus MD targets cannabis companies with proven brands, strong customer focus, and significant growth potential. We not only provide capital to meet these objectives but also years of management experience from a team that has been successful in all facets of business from start-ups to running large international organizations. The fundamental core of our operations is centered on the vast opportunities within fragmented industries in the cannabis space.

Invictus MD works in partnership with management teams to increase shareholder value through business planning and process integration, developing and executing growth strategies, leveraging our experience and relationships, and structuring and deploying the proper capital to support long-term growth. Our prudent approach to both investing in and developing successful companies ensures successful execution of the business plan in both times of economic expansion and contraction.

For more information please visit www.invictus-md.com.

On Behalf of the Board,

Dan Kriznic

Chairman & CEO

604-368-6437

Cautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed spin-out of Future Harvest, are forward-looking statements and contain forward-looking information.  Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”.  Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the proposed spin-out of Future Harvest will occur as anticipated, that the Company will obtain all requisite approvals of the spin-out transaction, and they are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed spin-out may not occur as planned; the timing and receipt requisite approvals. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended.  There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.  Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information.  Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws.  We seek safe harbour.